Open AccessImpact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial
Author(s) -
Giuseppe Ricci
Publication year - 2004
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh185
Subject(s) - partial thromboplastin time , medicine , luteal phase , endocrinology , t plasminogen activator , follicle stimulating hormone , plasminogen activator , fibrinogen , prothrombin time , urinary system , coagulation , hormone , luteinizing hormone
It has recently been suggested that recombinant FSH administration may result in an increased risk of venous thrombosis. An open-label, randomized, controlled trial was carried out to compare the impact of urinary and recombinant FSH on haemostasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom